Medtronic has announced that it’s begun testing a new surgical aortic heart valve in a global prospective clinical trial. The investigational device was implanted in the first patient at the ProMedica Toledo Hospital in Ohio.
The bovine pericardial valve features a low profile and leaflets mounted on the interior of the device. It’s designed to either be used as a replacement for previously implanted prosthetic valves or for transcatheter delivery for valve-in-valve procedures. The trial will be testing the device for ease of implantation, durability, and for therapeutic performance preventing regurgitation and maintaining healthy hemodynamics.
“I am thrilled to be the first physician in the U.S. to implant this innovative pericardial heart valve for patients with aortic stenosis. Based on my involvement in the trial, the valve’s new design makes it easy to implant, which may offer important advantages critical to long-term patient outcomes,” said Michael Moront, M.D., FACS, cardiovascular surgeon at the ProMedica Toledo Hospital in Toledo, Ohio. “We look forward to confirming this through the results from this trial.”